Shared decision making
What it is
Shared decision making belongs where the evidence alone does not decide the matter. The patient is informed of the risks and benefits of the options, and the decision is made together with the patient, and with the family when they are there. It is the note set beside the tests and treatments that are controversial, or individualized, or whose benefit sits close to their risk.
How it is treated
The named places where it is used:
- Prostate cancer screening with PSA, with or without DRE. Shared decision-making is usually at age 50-69, and the screening is controversial and individualized.
- A statin at a 10-year ASCVD risk of 5-7.4%: consider moderate-intensity if risk enhancers are present, with shared decision-making as the note. Above age 75 a statin is considered if the patient is likely to benefit, individualized on frailty and comorbidities.
- Uncomplicated appendicitis in a stable adult who prefers to avoid surgery: non-operative management with antibiotics, safety-netting, and discussion of recurrence risk.
- Oral anticoagulation in an older patient with atrial fibrillation: the benefits and risks are weighed together with the patient and the family.
What the discussion has to carry is set out most fully for appendicitis. Non-operative management is supported provided shared decision-making covers recurrence and failure and there is robust follow-up. The patient is informed of the risks and benefits of non-operative against operative management, there is reliable follow-up, and the patient is aware of the signs of treatment failure: persistent or worsening pain, fever, and clinical deterioration.
The numbers behind that discussion are part of it. A systematic review showed antibiotics as first-line in adults with uncomplicated appendicitis achieved about 58 to 75% 1-year success in avoiding surgery, with no increase in complications when surgery was eventually needed, and the recurrence risk the patient has to understand is about 20 to 30% failure.